Will trametinib be reimbursed by medical insurance?
Trametinib is an oral tablet developed by GlaxoSmithKline (GSK). It was approved by the US FDA on May 29, 2013, under the trade name Mekinist. Trametinib is mainly used to treat unresectable or metastatic melanoma associated with BRAF (murine sarcoma oncogenic homolog B1 gene) V600E or V600K mutations. However, it should be noted that this drug is not recommended for patients who have already received BRAF inhibitor treatment.
Trametinib is a reversible inhibitor of mitogen-activated extracellular signal-regulated kinase1 (MEK 1/2). It affects the MAPK pathway by acting on the MEK protein (the upstream regulator of the extracellular signal-related kinase (ERK) pathway), thereby inhibiting cell proliferation. This mechanism of action allows trametinib to inhibit the growth of BRAF V600 mutation-positive melanoma cells both in vivo and in vitro.

While trametinib is excellent at treating certain types of melanoma, it can also come with some side effects, such as allergic reactions, blood clots, bleeding, shortness of breath, electrolyte problems, high blood pressure, kidney problems, blurred vision, and more. Therefore, when using trametinib, patients should pay close attention to their physical condition and promptly report any discomfort to their doctor. At the same time, strictly following the doctor's instructions and the usage and dosage on the drug instructions is also the key to ensuring the safety and effectiveness of the drug.
Currently, trametinib has been included in my country's medical insurance catalog. Each box of the original trametinib available for purchase in the domestic market contains30 tablets of 2 mg. After medical insurance reimbursement, the price is less than 12,000 yuan/box. As far as we know, generic versions of trametinib have been launched overseas, many of which are produced and sold by pharmaceutical factories in Laos. The specifications are the same as the original version, but the price is only about 1,900 yuan. Patient feedback shows that the generic version works well, and drugs can be selected based on actual needs. If in doubt, please consult a professional overseas medical consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)